In evaluating chronic liver disease on imaging, how should findings be interpreted with laboratory data?

In evaluating chronic liver disease on imaging, how should findings be interpreted with laboratory data?

• A. Correlate with clinical data only
• B. Correlate imaging signs with clinical data and laboratory results
• C. Correlate imaging signs with biopsy results only
• D. Ignore laboratory data

Answer: (B)

In evaluating chronic liver disease on imaging, you always interpret imaging findings in the context of both the clinical picture and the laboratory data. Imaging can reveal structural changes such as nodularity, liver size alteration, or signs of portal hypertension, but those features aren’t specific on their own. Lab data provide crucial information about liver function and disease activity—albumin and INR for synthetic function, bilirubin and cholestatic enzymes for excretory function, platelets for portal hypertension effects, and other markers that help indicate ongoing injury or decompensation. When you put the imaging signs together with lab results, you get a more accurate assessment of the presence, severity, and potential etiology of liver disease. Biopsy is not the default or only pathway; it’s considered when noninvasive imaging and labs don’t yield a clear diagnosis or grading is required, but the question emphasizes integrating imaging with laboratory data, which is the standard approach.

In evaluating chronic liver disease on imaging, you always interpret imaging findings in the context of both the clinical picture and the laboratory data. Imaging can reveal structural changes such as nodularity, liver size alteration, or signs of portal hypertension, but those features aren’t specific on their own. Lab data provide crucial information about liver function and disease activity—albumin and INR for synthetic function, bilirubin and cholestatic enzymes for excretory function, platelets for portal hypertension effects, and other markers that help indicate ongoing injury or decompensation. When you put the imaging signs together with lab results, you get a more accurate assessment of the presence, severity, and potential etiology of liver disease.

Biopsy is not the default or only pathway; it’s considered when noninvasive imaging and labs don’t yield a clear diagnosis or grading is required, but the question emphasizes integrating imaging with laboratory data, which is the standard approach.